Benjamin Bouchacourt

5PUBLICATIONS
13CO-AUTHORS
Haematological tumoursHaematologyTransplantation immunologyPhysiotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 27, 2026
Fludarabine, cyclophosphamide and 2 Gy TBI with PT-Cy as a single platform for haplo and unrelated donor allo-SCT in older AML or MDS patients.

|Mar 15, 2024
Durable engraftment after pharmacological pre-transplant immune suppression followed by reduced-toxicity myeloablative haploidentical stem cell transplantation in highly HLA-immunized adults with sickle cell disease.

Sabine Fürst, Emmanuelle Bernit, Faezeh Legrand

|Nov 04, 2023
Peripheral blood haploidentical hematopoietic cell transplantation for patients aged 70 years and over with acute myeloid leukemia or high-risk myelodysplastic syndrome.

Samia Harbi, Louison Brac de la Perriere, Benjamin Bouchacourt

|Aug 09, 2023
GVHD prophylaxis with post-transplant cyclophosphamide results in lower incidence of GVHD and allows faster immunosuppressive treatment reduction compared to antithymocyte globulin in 10/10 HLA-matched unrelated allogeneic hematopoietic cell transplantation.

François Dachy, Sabine Furst, Boris Calmels

|Feb 24, 2020
Post-remission therapy of adults aged 60 and older with acute myeloid leukemia in first complete remission: role of treatment intensity on the outcome.

B Bouchacourt, M A Hospital, C Zemmour

Pageof 1

Frequent Collaborators

4 joint publications

Boris Calmels

4 joint publications

Didier Blaise

4 joint publications

Raynier Devillier

3 joint publications

Pierre-Jean Weiller